These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1878054)

  • 21. Chemoprophylaxis for Haemophilus and meningococcal infections. Position paper, Royal Australasian College of Physicians.
    Isaacs D; Ferson M; Gilbert GL; Grimwood K; McIntyre P
    J Paediatr Child Health; 1994 Feb; 30(1):9-11. PubMed ID: 8148204
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of rifampin chemoprophylaxis on carriage eradication and new acquisition of Haemophilus influenzae type b in contacts.
    Glode MP; Daum RS; Boies EG; Ballard TL; Murray M; Granoff DM
    Pediatrics; 1985 Oct; 76(4):537-42. PubMed ID: 3900905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary rates of Haemophilus influenzae type b disease among day care contacts.
    Marks MI; Dorchester WL
    J Pediatr; 1987 Aug; 111(2):305-6. PubMed ID: 3497253
    [No Abstract]   [Full Text] [Related]  

  • 24. Rifampin chemoprophylaxis for household contacts of patients with invasive infections due to Haemophilus influenzae type b.
    Daum RS; Glode MP; Goldmann DA; Halsey N; Ambrosino D; Welborn C; Mather FJ; Willard JE; Sullivan B; Murray M; Johansen T
    J Pediatr; 1981 Mar; 98(3):485-91. PubMed ID: 7009819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemophilus influenzae type b in a nursery school: the value of biotyping.
    Prober CG; Ipp MM; Bannatyne RM
    Pediatrics; 1982 Feb; 69(2):215-8. PubMed ID: 6977129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccines: recommendations for immunization with recently and previously licensed vaccines.
    Pediatrics; 1993 Sep; 92(3):480-8. PubMed ID: 8361814
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of salivary concentrations of rifampin and cefaclor: a rationale for chemoprophylaxis of Hemophilus influenzae type b disease.
    Ginsburg CM; McCracken GH
    Clin Pediatr (Phila); 1982 Jul; 21(7):397-9. PubMed ID: 7044641
    [No Abstract]   [Full Text] [Related]  

  • 28. More on rifampin prophylaxis against Haemophilus influenzae b in day-care facilities.
    Broome CV; Mortimer EA; Katz SL; Fleming DW; Hightower AW
    N Engl J Med; 1988 Jan; 318(1):48-9. PubMed ID: 3257291
    [No Abstract]   [Full Text] [Related]  

  • 29. Trimethoprim and rifampin in combination for chemoprophylaxis of household contacts of patients with invasive infections due to Haemophilus influenzae type b.
    Daum RS; Glode MP; Ambrosino D; Halsey N; Goldmann DA; Mather FJ; Russell R; Kamon J; Murray M; Band JD
    Antimicrob Agents Chemother; 1983 Nov; 24(5):658-62. PubMed ID: 6607027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of rifampin and ampicillin in day care center contacts of Haemophilus influenzae type b disease.
    Gessert C; Granoff DM; Gilsdorf J
    Pediatrics; 1980 Jul; 66(1):1-4. PubMed ID: 6967580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoprophylaxis for Haemophilus influenzae type b.
    Cartwright KA; Begg NT; Hull D
    BMJ; 1991 Mar; 302(6776):546-7. PubMed ID: 2021714
    [No Abstract]   [Full Text] [Related]  

  • 32. Chemoprophylaxis for secondary Haemophilus influenzae type b disease.
    Cartwright KA; Begg NT; Hull D
    CDR (Lond Engl Rev); 1991 Jan; 1(1):R2-6. PubMed ID: 1669742
    [No Abstract]   [Full Text] [Related]  

  • 33. Duration of rifampin chemoprophylaxis for contacts of patients infected with Haemophilus influenzae type B.
    Green M; Li KI; Wald ER; Guerra N; Byers C
    Antimicrob Agents Chemother; 1992 Mar; 36(3):545-7. PubMed ID: 1622163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemophilus influenzae type b disease after rifampin prophylaxis in a day care center: possible reasons for its failure.
    Murphy TV; McCracken GH; Moore BS; Gulig PA; Hansen EJ
    Pediatr Infect Dis; 1983; 2(3):193-8. PubMed ID: 6602974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of vaccines and antibiotic prophylaxis in contacts and cases of Haemophilus influenzae type b (Hib) disease.
    Cartwright KA; Begg NT; Rudd PT
    Commun Dis Rep CDR Rev; 1994 Feb; 4(2):R16-7. PubMed ID: 7511459
    [No Abstract]   [Full Text] [Related]  

  • 36. New Haemophilus influenzae type b control strategy: premature commitment to prophylaxis?
    Mann JM; Hull HF
    Pediatrics; 1983 Jul; 72(1):118-21. PubMed ID: 6306544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rifampicin prophylaxis for throat carriage of Haemophilus influenzae type b in patients with invasive disease and their contacts.
    Gilbert GL; MacInnes SJ; Guise IA
    BMJ; 1991 Jun; 302(6790):1432-5. PubMed ID: 2070109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haemophilus disease after rifampin prophylaxis.
    Wald ER
    Pediatr Infect Dis J; 1987 Nov; 6(11):1072. PubMed ID: 3501101
    [No Abstract]   [Full Text] [Related]  

  • 39. [Guidelines for the chemoprophylaxis of meningitis caused by Haemophilus influenzae type B].
    Hoppe JE; Helwig H; Isenberg H; Noack R
    Monatsschr Kinderheilkd; 1991 Dec; 139(12):849-50. PubMed ID: 1770963
    [No Abstract]   [Full Text] [Related]  

  • 40. Secondary Haemophilus influenzae type b in day-care facilities. Risk factors and prevention.
    Fleming DW; Leibenhaut MH; Albanes D; Cochi SL; Hightower AW; Makintubee S; Helgerson SD; Broome CV
    JAMA; 1985 Jul; 254(4):509-14. PubMed ID: 3874293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.